Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer;”
Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
ClinicalTrials.gov study NCT02872103. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer
ClinicalTrials.gov study NCT00572728. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
ClinicalTrials.gov study NCT00524303. IPD Sharing: Not stated. Countries: 1. Publications: 2.
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
ClinicalTrials.gov study NCT01125566. IPD Sharing: Not stated. Countries: 38. Publications: 1.
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
ClinicalTrials.gov study NCT01358877. IPD Sharing: YES. Countries: 42. Publications: 9.
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
ClinicalTrials.gov study NCT03676257. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of PRP Treatment for Hair Loss After Cancer Therapy in Women With Breast Cancer
ClinicalTrials.gov study NCT04459650. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT02675231. IPD Sharing: YES. Countries: 14. Publications: 2.
Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F)
ClinicalTrials.gov study NCT06946238. IPD Sharing: YES. Countries: 1. Publications: 46.
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
ClinicalTrials.gov study NCT00390455. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
ClinicalTrials.gov study NCT00310180. IPD Sharing: Not stated. Countries: 8. Publications: 11.
Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases
ClinicalTrials.gov study NCT01441596. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Fresolimumab and Radiotherapy in Metastatic Breast Cancer
ClinicalTrials.gov study NCT01401062. IPD Sharing: NO. Countries: 1. Publications: 3.
Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs
ClinicalTrials.gov study NCT00461253. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients
ClinicalTrials.gov study NCT00432172. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
ClinicalTrials.gov study NCT00050167. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.
ClinicalTrials.gov study NCT00356148. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
ClinicalTrials.gov study NCT00791037. IPD Sharing: NO. Countries: 1. Publications: 1.
Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients
ClinicalTrials.gov study NCT03847311. IPD Sharing: NO. Countries: 1. Publications: 18.
Lapatinib In Combination With Trastuzumab Versus Lapatinib Monotherapy In Subjects With HER2-positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00320385. IPD Sharing: Not stated. Countries: 13. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.